TGTX
Price
$53.89
Change
-$1.50 (-2.71%)
Updated
Sep 11 closing price
Capitalization
8.25B
58 days until earnings call
Intraday BUY SELL Signals
URGN
Price
$42.31
Change
+$0.07 (+0.17%)
Updated
Sep 11 closing price
Capitalization
2.07B
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

TGTX vs URGN

TGTX vs URGN Comparison Chart in %
View a ticker or compare two or three
VS
TGTX vs. URGN commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TGTX is a Hold and URGN is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TGTX($8.25B) has a higher market cap than URGN($2.07B). TGTX (80.778) and URGN (80.658) have similar YTD gains . TGTX has higher annual earnings (EBITDA): 139M vs. URGN (-79.25M). TGTX has more cash in the bank: 552M vs. URGN (108M). URGN has less debt than TGTX: URGN (196M) vs TGTX (754M). TGTX has higher revenues than URGN: TGTX (800M) vs URGN (189M).
TGTXURGNTGTX / URGN
Capitalization8.25B2.07B399%
EBITDA139M-79.25M-175%
Gain YTD80.77880.658100%
P/E Ratio19.67N/A-
Revenue800M189M423%
Total Cash552M108M511%
Total Debt754M196M385%
FUNDAMENTALS RATINGS
TGTX vs URGN: Fundamental Ratings
TGTX
URGN
OUTLOOK RATING
1..100
8789
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
58
Fair valued
PROFIT vs RISK RATING
1..100
4933
SMR RATING
1..100
14100
PRICE GROWTH RATING
1..100
3635
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

URGN's Valuation (58) in the Biotechnology industry is in the same range as TGTX (78). This means that URGN’s stock grew similarly to TGTX’s over the last 12 months.

URGN's Profit vs Risk Rating (33) in the Biotechnology industry is in the same range as TGTX (49). This means that URGN’s stock grew similarly to TGTX’s over the last 12 months.

TGTX's SMR Rating (14) in the Biotechnology industry is significantly better than the same rating for URGN (100). This means that TGTX’s stock grew significantly faster than URGN’s over the last 12 months.

URGN's Price Growth Rating (35) in the Biotechnology industry is in the same range as TGTX (36). This means that URGN’s stock grew similarly to TGTX’s over the last 12 months.

TGTX's P/E Growth Rating (99) in the Biotechnology industry is in the same range as URGN (100). This means that TGTX’s stock grew similarly to URGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TGTXURGN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 11 days ago
84%
Bullish Trend 10 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
83%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (TGTX: $53.89 vs. URGN: $42.31)
Brand notoriety: TGTX and URGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TGTX: 68% vs. URGN: 81%
Market capitalization -- TGTX: $8.25B vs. URGN: $2.07B
TGTX [@Biotechnology] is valued at $8.25B. URGN’s [@Biotechnology] market capitalization is $2.07B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TGTX’s FA Score shows that 1 FA rating(s) are green while URGN’s FA Score has 1 green FA rating(s).

  • TGTX’s FA Score: 1 green, 4 red.
  • URGN’s FA Score: 1 green, 4 red.
According to our system of comparison, TGTX is a better buy in the long-term than URGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TGTX’s TA Score shows that 4 TA indicator(s) are bullish while URGN’s TA Score has 4 bullish TA indicator(s).

  • TGTX’s TA Score: 4 bullish, 5 bearish.
  • URGN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both TGTX and URGN are a bad buy in the short-term.

Price Growth

TGTX (@Biotechnology) experienced а -3.74% price change this week, while URGN (@Biotechnology) price change was -4.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

TGTX is expected to report earnings on Nov 09, 2026.

URGN is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
TGTX
Daily Signal:
Gain/Loss:
URGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FDRV16.890.24
+1.46%
Fidelity Elctrc Vhcls & Ftr Trnsptn ETF
XFLT19.520.17
+0.88%
XAI Floating Rate & Alternative Income Trust
VTWG268.401.51
+0.57%
Vanguard Russell 2000 Growth ETF
IGI15.670.07
+0.45%
Western Asset Investment Grade Opportunity Trust Inc
VCX33.50N/A
N/A
Fundrise Innovation Fund, LLC

TGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with ARQT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then ARQT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGTX
1D Price
Change %
TGTX100%
-2.71%
ARQT - TGTX
40%
Loosely correlated
+2.16%
ARRY - TGTX
36%
Loosely correlated
+1.54%
CLLS - TGTX
36%
Loosely correlated
+1.64%
KRYS - TGTX
36%
Loosely correlated
+0.42%
IMCR - TGTX
36%
Loosely correlated
-2.92%
More

URGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, URGN has been loosely correlated with AIM. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if URGN jumps, then AIM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To URGN
1D Price
Change %
URGN100%
+0.17%
AIM - URGN
39%
Loosely correlated
-2.29%
PHAT - URGN
38%
Loosely correlated
-0.12%
JANX - URGN
37%
Loosely correlated
-3.28%
TECX - URGN
33%
Loosely correlated
+1.54%
TGTX - URGN
33%
Poorly correlated
-2.71%
More